Catalysts for Genentech Inc
166 tracked
May 28, 2020
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
May 28, 2020
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
May 18, 2020
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Mar 27, 2020
approval
GAZYVA (OBINUTUZUMAB) — FDA approval
obinutuzumab
→
Dec 3, 2019
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Jun 11, 2019
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jun 11, 2019
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jun 10, 2019
approval
POLIVY (POLATUZUMAB VEDOTIN-PIIQ) — FDA approval
polatuzumab vedotin
→
May 6, 2019
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
May 6, 2019
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
May 3, 2019
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Apr 11, 2019
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Apr 11, 2019
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Apr 11, 2019
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Mar 18, 2019
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Mar 8, 2019
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Dec 20, 2018
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Dec 20, 2018
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Dec 18, 2018
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Dec 6, 2018
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Nov 19, 2018
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Nov 19, 2018
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Sep 20, 2018
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Sep 12, 2018
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Sep 12, 2018
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jul 2, 2018
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Jun 26, 2018
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Jun 19, 2018
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
Jun 14, 2018
approval
TECENTRIQ (ATEZOLIZUMAB) — FDA approval
atezolizumab
→
May 17, 2018
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→